Lund, Eiliv

Lund, Eiliv

Professor, permisjon til aug. 2007

Telefon (+47)
77 64 48 45

E-post
eiliv.lund@ism.uit.no

Kontor
MH-bygget, plan 10, rom 10.230

Fagseksjon
Epidemiologi og medisinsk statistikk

Biografiske data
Born in Bergen, Norway, 21. of November 1947.
Place of living Tromsø, North Norway
Formal education
Medical School at the University of Oslo, M.D. 1974
One year university study in psychology, Oslo, 1970
One year course in statistics, University of Oslo 1981

Dr.Med.Sci 1989 at the University of Oslo; "Oral contraceptive use and premenopausal breast cancer"

Positions and Employment

1979-1984 Research fellow, The Norwegian Cancer Registry. Working with registration and classification including evaluation of the data quality. Participated in register publications on incidence and survival of cancer in Norway and international publications on occupational cancer.

1985-1989 Senior researcher, The Norwegian Radiumhospital. Responsible for the Clinical Trial Branch in which 10-12 trials om different cancer treatment modalitites were running simultaneously. In addition, responsible for a Scandinavain case-control study of premenopausal breastcancer.

1989 1/2 year Special consultant in epidemiology, Directorate of health.

1990-1991 Assistant professor in epidemiology, University of Tromsø.

1991 Professor in epidemiology, University of Tromsø.

Committes relevant for the application;
2000 head of the board of the Sami Health Research Institute, financed from the Ministry of social affairs and health.

2000 Member of the Steering Comittee of the EPIC study – "European Prospective Investigation into Nutrition and Cancer"

2002 – member of the Executive Scientific board at the Norwegian Cancer Society

Utvalgte publikasjoner

• Lund E. Number of children and death from hormone- dependent cancers. Int J Cancer 1990; 46; 998-1000.


• Lund E, Bønnaa K. Reduced breast cancer mortality among fishermen's wives in Norway. Cancer Causes Controls 1993; 4; 283-7.


• Lund E (editorial). The research tide ebbs for the dietary fat hypothesis in breast cancer. Epidemiology 1994; 5; 387-8.


• Collaborative group on hormonal factors in breast cancer. Breast cancer and hormonal contraceptives. Lancet 1996; 347; 1713-27


• Kumle M, Weiderpass E, Braaten T, Adami HO, Lund E Oral contraceptive use and breast cancer - Hormonal contraceptives and breast cancer risk in Norway and Sweden. The Women’s Lifestyle and Health Cohort Study. Cancer Epi Biomarkers Prev 2002;

Annet
The annual price from the Norwegian Cancer Society 2002 of Nkr 500.000, the King Olav V Cancer Research Award.